Global pharmaceutical leaders will convene in Islamabad on the 24th to participate in a high-level strategic dialogue focused on three interlinked priorities medicine exports AI integration and elevated quality standards The event is expected to bring together key industry executives regulators government officials and policy experts to chart a roadmap for Pakistan’s pharmaceutical sector growth

The discussions will address how Pakistan can increase its share in global medicine exports by overcoming regulatory barriers improving compliance with international standards and adopting artificial intelligence tools for quality assurance The regulatory reforms under review include strengthening drug registration systems supply chain integrity and laboratory testing protocols

AI-based solutions are expected to feature prominently in sessions exploring predictive quality control real-time monitoring and automation in drug manufacturing This technological push aims to reduce human error accelerate regulatory reviews and ensure that exported medicines meet the strictest safety efficacy and quality criteria

Participants will also share best practices for export market access trade financing and partnerships with foreign regulatory bodies Those attending are preparing proposals for streamlined export policies incentives for compliance and infrastructure investment to support expanded capacity

The Islamabad gathering signals Pakistan’s intent to position its pharmaceutical industry not only as a major global exporter but also as a centre of innovation and quality assurance By bringing together stakeholders from industry regulatory bodies and technology providers this event may lead to lasting partnerships that will shape the future of medicine manufacturing and export in Pakistan